MS Pharma has announced the appointment of Mr. Kalle Känd as the new CEO for the group. Kalle joins MS Pharma with 27 years of global and regional experience in the pharmaceutical and generic space, where he has assumed various senior leadership positions at highly successful pharmaceutical companies.
Previously, Kalle was the CEO of Acino International, a successful international branded generic business active in emerging markets, where he oversaw the company’s business mainly in the middle east and Africa.
As the Chief Executive Officer, Kalle will be responsible for driving the company’s ambitious growth plans and expansions inside and outside the MENA region.
On this occasion, Mr. Ghiath Sukhtian, MS Pharma Chairman, expressed proudly “MS Pharma is very excited to have Kalle on board, where he is ideally positioned to take on this new leadership role with us. He has a strong record of commercial and operational leadership and I am confident that he will create significant value for our company, stakeholders and shareholders”.
From his side, Kalle said, “I am very optimistic about my new journey; I strongly believe it is a transformational time to join MS Pharma where we will build on recent successes to lead the company into its next phase of growth”.